Home » Stocks » CC

The Chemours Company (CC)

Stock Price: $26.79 USD -0.24 (-0.89%)
Updated Jan 26, 2021 4:00 PM EST - Market closed
Market Cap 4.45B
Revenue (ttm) 4.98B
Net Income (ttm) -117.00M
Shares Out 164.24M
EPS (ttm) -0.72
PE Ratio n/a
Forward PE 10.52
Dividend $1.00
Dividend Yield 3.73%
Trading Day January 26
Last Price $26.79
Previous Close $27.03
Change ($) -0.24
Change (%) -0.89%
Day's Open 27.18
Day's Range 26.51 - 27.30
Day's Volume 979,077
52-Week Range 6.94 - 28.70

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Zacks Investment Research - 1 day ago

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to th...

Market Watch - 4 days ago

DuPont de Nemours Inc. , Corteva Inc. and Chemours Co. announced Friday an agreement to settle legal disputes, and to establish a cost-sharing arrangement related to PFAS liabilities. Under te...

Other stocks mentioned: CTVA, DD
PRNewsWire - 4 days ago

WILMINGTON, Del., Jan. 22, 2021 /PRNewswire/ -- DuPont de Nemours, Inc. (NYSE: DD), Corteva, Inc. (NYSE: CTVA) and The Chemours Company (NYSE: CC) today announced they have entered into a bind...

Other stocks mentioned: CTVA, DD
PRNewsWire - 4 days ago

WILMINGTON, Del., Jan. 21, 2021 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in Fluoroproducts, Titanium Technologies, a...

Zacks Investment Research - 1 week ago

Is (CC) Outperforming Other Basic Materials Stocks This Year?

Zacks Investment Research - 1 week ago

Expectations about stimulus package, Fed's supportive stance, and vaccine rollout have helped investors remain optimistic, which calls for investing in growth stocks like D.R. Horton (DHI) and...

Other stocks mentioned: ALTM, DHI, DOCU, HOG
Zacks Investment Research - 1 week ago

Chemours (CC) possesses solid growth attributes, which could help it handily outperform the market.

Zacks Investment Research - 2 weeks ago

Does Chemours (CC) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Investment Research - 2 weeks ago

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to th...

Zacks Investment Research - 2 weeks ago

Chemours (CC) gains on a recovery in demand from the coronavirus-induced slowdown, strong execution and its cost-reduction measures.

Zacks Investment Research - 2 weeks ago

Investors target stocks that have been on a bullish run, lately. Stocks seeing price strength have higher chances of carrying the momentum ahead.

Other stocks mentioned: DAN, HUN, LEA, MGA, VSTO
Zacks Investment Research - 2 weeks ago

The chemical industry has recovered from the pandemic-led slump and looks set for an upturn this year on a rebound in end-market demand. CBT, HUN, CC, PPG and CE to gain from the industry's re...

Other stocks mentioned: CBT, CE, HUN, PPG
PRNewsWire - 3 weeks ago

WILMINGTON, Del., Jan. 5, 2021 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Fluoroproducts and...

Zacks Investment Research - 4 weeks ago

A rebound in China, demand upturn across major markets and recovering manufacturing activities augur well for the chemical industry heading into 2021.

Other stocks mentioned: ESI, KWR, SHECY, CVVTF, COVTY
Zacks Investment Research - 4 weeks ago

4 Diversified Chemical Stocks Set to Ride the Industry's Upturn

Other stocks mentioned: CBT, KOP, PPG
Zacks Investment Research - 4 weeks ago

Chemours (CC) benefits from demand recovery, cost-management initiatives and strong execution.

Zacks Investment Research - 1 month ago

Let's see if The Chemours Company (CC) stock is a good choice for value-oriented investors right now from multiple angles.

Zacks Investment Research - 1 month ago

The U.S. chemical industry is poised for an upturn next year on a rebound across major end-markets and a recovery in chemical exports.

Other stocks mentioned: CBT, ESI, KWR, TSE
Zacks Investment Research - 1 month ago

Does Chemours (CC) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Investment Research - 1 month ago

Chemours (CC) gains on a recovery in demand from the coronavirus-induced slowdown and its cost-reduction measures.

Seeking Alpha - 1 month ago

CC has received multiple upward earnings revisions from analysts over the past month. CC has very attractive 10% - 12% options yields, which are detailed at the end of this article.

Zacks Investment Research - 1 month ago

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to th...

Zacks Investment Research - 1 month ago

Chemours (CC) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research - 1 month ago

A rebound in demand across major end markets has put the wind back in the sails of the chemical industry.

Other stocks mentioned: CBT, DOW, KOP, PPG
Zacks Investment Research - 1 month ago

Chemours (CC) benefits from demand recovery across its markets and its cost-cutting actions.

Bloomberg Technology - 1 month ago

Chemours Will Benefit From Biden Climate Spending: CEO

Nov.30 -- Chemours Chief Executive Officer Mark Vergnano discusses debt reduction efforts, acquisition strategy, and global growth outlook with Bloomberg's Ed Hammond on "Bloomberg Markets: Th...

Zacks Investment Research - 1 month ago

Chemours (CC) to use the net proceeds along with cash on hand to finance the purchase price as well as unpaid and accrued interest of senior notes due 2023.

PRNewsWire - 1 month ago

WILMINGTON, Del., Nov. 27, 2020 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC), a global chemistry company with leading market positions in Fluoroproducts, Chemical Solutions and...

PRNewsWire - 2 months ago

WILMINGTON, Del., Nov. 25, 2020 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC), a global chemistry company with leading market positions in Fluoroproducts, Chemical Solutions and...

Zacks Investment Research - 2 months ago

Does Chemours (CC) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Investment Research - 2 months ago

Chemours (CC) seems to be a good value pick, as it has decent revenue metrics to back up its earnings, and is seeing solid earnings estimate revisions as well.

Zacks Investment Research - 2 months ago

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to th...

Zacks Investment Research - 2 months ago

Chemours (CC) to employ the net proceeds along with cash on hand to fund the purchase price as well as unpaid and accrued interest of senior notes due 2023.

PRNewsWire - 2 months ago

WILMINGTON, Del., Nov. 12, 2020 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC), a global chemistry company with leading market positions in Fluoroproducts, Chemical Solutions and...

Market Watch - 2 months ago

Chemicals company The Chemours Co. said Thursday it is offering $750 million of senior notes in a private offering, joining the many companies raising record levels of capital during the pande...

PRNewsWire - 2 months ago

WILMINGTON, Del., Nov. 12, 2020 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC), a global chemistry company with leading market positions in Fluoroproducts, Chemical Solutions and...

PRNewsWire - 2 months ago

WILMINGTON, Del., Nov. 12, 2020 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC), a global chemistry company with leading market positions in Fluoroproducts, Chemical Solutions and...

Zacks Investment Research - 2 months ago

Chemours (CC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Seeking Alpha - 2 months ago

The Chemours Company (CC) CEO Mark Vergnano on Q3 2020 Results - Earnings Call Transcript

Schaeffers Research - 2 months ago

The shares of The Chemours Company (NYSE:CC) are up 1% at $21.98 at last check, after the chemical company reported better-than-anticipated third-quarter earnings, as well as revenue just abov...

Zacks Investment Research - 2 months ago

Lower volumes and prices hurt sales across Chemours' (CC) Fluoroproducts and Chemical Solutions segments in Q3.

Zacks Investment Research - 2 months ago

Chemours (CC) delivered earnings and revenue surprises of 46.88% and 5.20%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

PRNewsWire - 2 months ago

WILMINGTON, Del., Nov. 3, 2020 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in Fluoroproducts, Chemical Solutions and Ti...

Insider Monkey - 2 months ago

Miller Value Partners recently released its Q3 2020 Investor Letter, a copy of which you can download here. In the third quarter, the Miller Income Strategy fund returned 7.89% versus 4.71% fo...

PRNewsWire - 2 months ago

WILMINGTON, Del., Oct. 28, 2020 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in titanium technologies, fluoroproducts an...

PRNewsWire - 3 months ago

WILMINGTON, Del., Oct. 14, 2020 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in fluoroproducts, titanium technologies, a...

PRNewsWire - 3 months ago

WILMINGTON, Del., Sept. 30, 2020 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in fluoroproducts, titanium technologies, ...

PRNewsWire - 4 months ago

WILMINGTON, Del., Sept. 8, 2020 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in titanium technologies, fluoroproducts an...

Seeking Alpha - 4 months ago

CC has outperformed the peers YTD.

Zacks Investment Research - 4 months ago

Chemours (CC) reported earnings 30 days ago. What's next for the stock?

About CC

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Fluoroproducts, Chemical Solutions, and Titanium Technologies. The Fluoroproducts segment offers fluorochemicals, including refrigerants, foam blowing agents, and propellants under the Freon and Opteon brand names; fluoropolymers, such as industrial resins, specialty products, and coatings under the Teflon, Viton, Krytox, and Nafion brands; and fluoroelastomer products un... [Read more...]

Industry
Specialty Chemicals
Founded
2014
CEO
Mark Vergnano
Employees
7,000
Stock Exchange
NYSE
Ticker Symbol
CC
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to 11 analysts, the average rating for CC stock is "Hold." The 12-month stock price forecast is 28.00, which is an increase of 4.52% from the latest price.

Price Target
$28.00
(4.52% upside)
Analyst Consensus: Hold